In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity
A class of innovative benzimidazole-1,3,4-Oxadiazole derivatives is a significant heterocyclic molecule for therapeutic development. In heterocyclic chemistry, the novel 1,3,4-Oxadiazole nucleus has a wide range of uses, including antibacterial, treatment. Molecular docking is frequently employed in...
Main Authors: | Shivanand Kolageri, S Hemanth, Mahesh Parit |
---|---|
Format: | Article |
Language: | English |
Published: |
Creative Pharma Assent
2022-09-01
|
Series: | Journal of Applied Pharmaceutical Research |
Subjects: | |
Online Access: | https://japtronline.com/index.php/joapr/article/view/275 |
Similar Items
-
Synthesis, in silico analysis and antidepressant activity of 1,3,4-oxadiazole derivatives
by: Banylla Felicity Dkhar Gatphoh, et al.
Published: (2022-03-01) -
Synthesis, characterization and antimicrobial activity of 1,3,4-oxadiazole bearing 1H-benzimidazole derivatives
by: Salahuddin, et al.
Published: (2017-02-01) -
Synthesis of Some New Substituted 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Derivatives
by: Amena A. Ahmed
Published: (2018-06-01) -
Synthesis and characterization of 5-aryl-1,3,4-oxadiazole-2(3h)thione derivatives
by: Shailesh Pathak, et al.
Published: (2020-11-01) -
Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review
by: Jing-Jing Wang, et al.
Published: (2022-12-01)